insider24.ch
Back to the feed

Shareholding disclosure

Consonance Capital Management LP

inSanthera Pharmaceuticals Holding AG

Declared position

9.99%

Threshold

Crossed upwards

Timeline

Published

26.02.2016

Transaction

22.02.2016

Voting rights breakdown

Voting rights acquired9.99%
Voting rights sold0%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAG2O00011

Beneficial owner

Consonance Capital Management LP

Declared address

Consonance Capital Management LP, New York, NY 10019

This disclosure notification is not being made under the new Swiss Financial Market Infrastructure Act which entered into force on 1 January, 2016. Consonance Capital Opportunity Fund Management LP, 1370 Avenue of the Americas, Suite 3301, New York, NY 10019 is an affiliated manager of Consonance Capital Management, L.P. Consonance Capital Opportunity Fund Management. LP manages P Consonance Opportunities Ltd, a separately managed account.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open